Back To: Home : Resources : White Papers



White Papers
White Paper
Thermo Fisher
Many biological science applications require an accurate, precise measurement of the number of cells and their viability prior to downstream analysis. This assessment
can be done manually with a traditional hemocyotmeter and microscope or with an automated cell counter, such as the Invitrogen™ Countess™ II FL.
For the vast number of scientists that undertake handheld pipetting protocols - INTEGRA has produced a highly informative illustrated 'Best Practices' guide. Drawing upon decades of pipetting experience - INTEGRA has compiled an unbiased series of hints and tips to help you improve your handheld pipetting. Expert advice is provided in areas including before you start, how to pipette and optimising pipetting performance.  Each area of best pipetting practice discussed is backed up with an explanation of why this produces optimal results.
Genetic_Disease_icon Register for the Illumina Genomics Symposium
Next-Generation Sequencing Applications  for Neurological Disorders

Today, cell biologists are looking to new methods, like next-generation sequencing, to investigate the genetic underpinnings of disease biology and generate hypotheses for further studies that analyze gene expression and protein function.
Brooks New paper
Breaking the Bottleneck: Boosting Lab Performance with Automated Plate Seal Removal

Removing and/or replacing hundreds of plate seals at a time can represent a formidable and painstaking challenge. This paper reviews how high-throughput screening (HTS) and high-content screening (HCS) laboratories discovered hidden productivity improvements using new adhesive-based de-sealing technology.
Gilson, Inc.
Quanterix Corporation
Bio-Rad Laboratories The story of Leukemia research is being re-written—one droplet at a time. See how droplet digital PCR gives scientists the power to detect what was previously undetectable. Watch Video
BioTek Instruments, Inc. 
 Quanterix Corporation
BioTek Instruments
Mirus Bio, LLC 
Differentiation and reprogramming techniques are imperative in stem cell research and require virus-free applications for biotherapeutic and new drug development. Mirus Bio presents a suite of TransIT® Transfection Reagents and an Ingenio® Electroporation Kit that are high efficiency, low toxicity DNA and RNA delivery solutions validated for a variety of stem cell applications.  
Hamilton Company
Applied Photophysics Ltd
  To decrease the frequency of system repairs and contamination, a series of steps have been outlined for maintenance and care of a chromatographic system and columns used for the analysis of biomolecules.
Waters Corp.
Gilson, Inc
Applied Photophysics Ltd
INDIGO Biosciences, Inc.
Bio-Rad Laboratories
Shimadzu Scientific Instruments 
Gilson, Inc
Bio-Rad Laboratories
Applied Photophysics Ltd  
Strategies to compare far-UV Circular Dichroism spectra of similar proteins using Chirascan™-plus ACD  
JMP Clinical
JMP Clinical has a number of analytical processes (APs) that calculate and compare the incidence of events between two or more treatment groups in a clinical trial. Interventions Incidence Screen enables you to compare the incidence of concomitant medications or substances. AE Incidence Screen enables you to compare the incidence of adverse events. DS/MH Incidence Screen enables you to compare disposition events (e.g., randomization or completion status) or medical history terms (which, technically, is a comparison of prevalence). Finally, AE Resolution Screen enables you to examine the resolution of adverse events. Most of these APs operate in a similar manner. In this white paper, we use AE Incidence Screen with sample data to illustrate the common functionality of these APs. We also point out important differences among the other APs at the end of the example
Lucigen Corporation
EMD Millipore
Profiling of putative lead compounds against a representative panel of important enzymes, receptors, ion channels and transporters is an excellent way to establish a preliminary view of potential issues that might later hamper development. An early idea of which off-target activities must be minimized can save valuable time and money during the preclinical lead optimization phase if pivotal questions are asked beyond the usual profiling at hERG. The best data for critical evaluation of activity at GPCRs and ion channels is obtained using functional assays, since binding assays cannot detect all interactions and do not provide information on whether the interaction is that of an agonist, antagonist, or allosteric modulator. This overview discusses the benefits of in vitro assays, specific decision points where profiling can be of immediate benefit, and highlights relevant profiling services offered by EMD Millipore. 
INDIGO Biosciences
SABiosciences, a QIAGEN company
Trevigen, Inc
Caliper Life Sciences 
Caliper Discovery Alliances & Services
Ariadne Genomics
Gilson, Inc
SABiosciences, a QIAGEN company
Accuri Cytometers, Inc.
MD Biosciences, Inc
Invitrogen by Life Technologies
Accuri Cytometers, Inc.
BioTek Instruments, Inc.
Invitrogen by Life Technologies
R&D Systems, Inc.
R&D Systems, Inc.
Trevigen, Inc.
SANYO Biomedical
Caliper Life Sciences
The Baker Company
Back West, Inc. and Jumpstart Biodevelopment
AstraZeneca LP
Adeptia Inc.

Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
© Copyright 2015 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.